Over the last five years, Portugal has built a reputation as the medical cannabis ‘doorway to Europe’, the go-to hub
Airo Brands, a US multi-state CPG company focused on proprietary cannabis products, in partnership with Jupiter Research LLC, has received
The study validates SOMAÍ’s patent-pending process for producing Full-Spectrum Extract Cannabis Oil (FECO), offering new scientific evidence that bridges pharmaceutical precision with consistent, patient-friendly formulations.
As rumours continue to circulate about the identity of the international criminal gang targeted in last week’s Portuguese busts, a key industry player has warned of potential supply disruption to the country’s medical cannabis patients.
Mamedica has today announced an exclusive partnership with Cookies to offer its premium pharmaceutical products to patients across the UK.
Multi-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that market matures and expansion opportunities dwindle a new trend is emerging – the rise of ‘multi-country operators’ (MCOs).
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, is proud to announce its entry into
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) with the most advanced cannabinoid pharmaceutical extract portfolio, has partnered
SOMAÍ Pharmaceuticals is proud to announce a strategic partnership with Releaf, the UK’s fastest-growing medical cannabis clinic, to bring innovative
SOMAÍ Pharmaceuticals (“SOMAÍ”), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
